Spironolactone News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Spironolactone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Spironolactone Today - Breaking & Trending Today

Why are dermatologists prescribing women a blood pressure drug for acne?

According to a study in JAMA Dermatology, the prescribing rates of spironolactone for acne in women rose about 300% from 2017 to 2020. ....

United States , New York , John Barbieri , Ayman Grada , Christopher Bunick , Jessica Krant , Skin Surgery Center , Yale University School Of Medicine , American Academy Of Dermatology , Drug Administration , Case Western Reserve University School Of Medicine , Case Western Reserve University School , American Academy , Yale University School , Blood Pressure , John Barbieri , Oral Antibiotics , Topical Medication , American Academy Of Dermatology ,

Spironolactone Misses Mark in Hemodialysis Trial

Primary results presented at ASN Kidney Week 2023 showed spironolactone missed the trial's primary endpoint. ....

United States , Boehringer Ingelheim Patrick Rossignol , Zannadf Massy , Patrick Rossignol , Monaco Private Haemodialysis Centre , American Society Of Nephrology Kidney Week , Boehringer Ingelheim , Antagonist Chronic , Interventional Survival Trial , American Society , Nephrology Kidney Week , Princess Grace Hospital , Paper Presented , Coral Route , Phase 3 , Chronic Kidney Disease ,

In Heart Failure Patients, Spironolactone Linked to Reduced Risk of Dementia, Alzheimers Disease

A propensity score-matched analysis of data suggests use of spironolactone could reduce the 3-year risk of developing Alzheimer disease or dementia among patients with heart failure with reduced ejection fraction. ....

United States , New York , Stony Brook , Andreas Kalogeropoulos , Cardiovascular Health Study , Division Of Cardiology At Stony Brook Medicine , Heart Society Of America , Artery Risk Development In Young Adults Study , Heart Society , Stony Brook Medicine , Atherosclerosis Risk , Communities Study , Coronary Artery Risk Development , Young Adults Study , Framingham Offspring Study , Multi Ethnic Study , Northern Manhattan Study , Confidence Interval , Hfsa 2023 , Cognitive Decline ,

Clinical Data on Finerenone in Diabetic Kidney Disease

Dr George Bakris reviews the clinical trial data for finerenone and provides insights on treatment selection, including the potential benefits of combination therapy with finerenone and SGLT2 inhibitors, in managing diabetic kidney disease. ....

George Bakris , Diabetic Kidney Disease , Diabetic Kidney , Chronic Kidney Disease , Sglt2 Inhibitors , Heart Failure , Ras Blocker , Ace Inhibitor , Calcium Blocker , Potassium Binders ,

PFO Long Term; Appropriate Use Ineffective in PCI?; MI in Exhausted Men

email article
Patent foramen ovale closure reduced recurrent strokes by a relative 69% at 5 years, with a number needed to treat of about 25 compared with antiplatelets alone in the REDUCE trial. (
New England Journal of Medicine)
Appropriate use criteria for PCI didn t do much to shift acuity away from stable disease in VA and Medicare cohorts, researchers reported. (
Circulation: Cardiovascular Quality and Outcomes)
Exhaustion marked by irritability and demoralization was linked with heart attack in men. (
Science Daily)
It s not just kids: Multisystem inflammatory syndrome linked with COVID-19 in children (MIS-C) should be considered by any clinician seeing adult patients who present acutely unwell with the same symptoms. ( ....

United States , American Heart Association , New England Journal , Cardiovascular Quality , Science Daily , Ranch Prepack , Endpoints News , Patent Foramen Ovale , Peer Review , Heart Disease , ஒன்றுபட்டது மாநிலங்களில் , அமெரிக்கன் இதயம் சங்கம் , புதியது இங்கிலாந்து இதழ் , இருதய தரம் , அறிவியல் தினசரி , பியர் விமர்சனம் , இதயம் நோய் ,